RCKT Rocket Pharmaceuticals, Inc.
$2.62▼ -1.32%
Unknown
Other
Last sync: 1m ago
Syncing
Key Metrics & Fundamentals
Market Cap
$285.54M
P/E Ratio
–
Div Yield
–%
52W Range
2.40 - 5.45
% vs 50 MA
-21.83%
% vs 200 MA
-25.57%
RSI-14
28.5
MACD Histogram
-0.0200
Beta (1Y vs SPY)
2.10
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
N/A
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Avg +0.92 · 4 posts
NewsDDTradeRocket Pharmaceuticals (RCKT) Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
r/wallstreetbets · Mar 27, 2026
The post announces FDA approval, a highly positive event for the company. The comments also indicate a pump and dump situation.
very_positive
+1.00
NewsDiscussionTradeRocket pharmaceuticals gets FDA approval (RCKT)
r/investing · Mar 27, 2026
The post expresses excitement about the FDA approval and anticipates a potential price jump, indicating a bullish sentiment.
positive
+0.80
NewsTradeRocket pharmaceuticals gets FDA approval (RCKT)
r/wallstreetbets · Mar 27, 2026
The post is celebrating FDA approval, a highly positive event for the company.
very_positive
+1.00
DDTradeNewsRCKT FDA APPROVAL AFTER HOURS LOOKIJG TO RUN IN PREMARKET
r/wallstreetbets · Mar 27, 2026
The post expresses strong optimism regarding RCKT's approval, potential gains, and financial health, using bullish language and emojis.
very_positive
+0.90
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.